STUDY QUESTION: What are the live birth rate and risks of obstetric complications following the surgical management of intrauterine adhesions (IUA) such as Asherman syndrome (AS)?
Introduction
The presence of intrauterine adhesions (IUA) following interventions during any type of pregnancy or intrauterine surgery in the non-gravid uterus is known to impact subsequent pregnancy (Roge et al., 1996; Feng et al., 1999; Thomson et al., 2007; Yu et al., 2008a; Roy et al., 2010) . The eponymous Asherman syndrome (AS) is defined as partial or complete obstruction of the uterine cavity by adhesions secondary to trauma of the corpus, with resulting menstrual abnormalities, cyclical lower abdominal pain, infertility, or recurrent pregnancy loss (Asherman, 1950) . Contemporary gynaecological surgery incorporates a wide variety of hysteroscopic procedures-both simple and complex-that may also result in IUA, with strong evidence that these too impact subsequent pregnancy (Pelage et al., 2000; Robinson et al., 2008; Sentilhes et al., 2010b; Fernandez et al., 2012; Myers and Hurst, 2012; Xiao et al., 2014) .
Clinical studies investigating surgical outcomes of IUAs report favourable menstrual and anatomic restoration, however, repeat surgery or re-formation of IUAs occurs in close to 1/3 of women despite successful initial surgery and subsequent supplementary measures such as adhesion barriers (Hanstede et al., 2015) . It is reported that increasing severity of disease is associated with poorer clinical outcomes (Fedele et al., 1986; Pabuccu et al., 1997) and a higher chance of repeat surgery required. Post-operative reproductive function is poorer than menstrual or other clinical outcomes, with pregnancy rates reported to range from 44 to 93% (Yu et al., 2008b; March, 2011) . The impact on pregnancy following surgical treatment of IUA is likely related to a deficiency in the residual endometrium (Polishuk et al., 1977; Lo et al., 2008) and myometrial fibroisis that may decrease vascular delivery of steroids to the endometrial tissue (Yaffe et al., 1978) or create an altered endometrial biochemical milieu, affecting implantation (Steinbrech et al., 1999) . The objective of this study is to report the live birth rate and other fertility, obstetric and neonatal outcomes following hysteroscopic synechiolysis in women treated for IUAs over a 14-year duration in two referral centres.
Materials and Methods

Ethical approval
Ethics approval for the study was granted by the SESLHD Ethics committee (approval number 07/207 24) to undertake a retrospective study for women treated surgically for IUAs between January 2000 and June 2014 at two tertiary referral hospitals in Sydney, Australia.
Study design
Inclusion criteria were symptomatic women aged between 18 and 51 years at index surgery with the majority wishing further fertility; IUAs diagnosed by hysteroscopy; English speaking or with an adequate interpreter available; and capable of providing informed consent. The exclusion criteria included suspected diagnosis of gynaecological malignancy or its precursors; postmenopausal status at the time of surgery; pre-existing tuberculosis; and no IUAs seen at hysteroscopic surgery.
Previous medical or surgical treatment for IUA was not a contraindication to entry into the study. Surgery was undertaken by, or under the supervision of two consultant gynaecologists with experience in synechiolysis of IUA using a surgical technique previously described (Thomson et al., 2007) . Briefly, this was undertaken with image intensifier control with fibrous adhesions lysed using a Tuouy needle parallel to the hysteroscope, or with the aid of hysteroscopic scissors without electrosurgery. This procedure may be subsequently repeated until the normal anatomy of the uterine cavity is restored in accordance with recommended guidelines (AAGL, 2013). As the surgeons were known to have expertise in the surgical division of IUA, with each having >10 years' experience in surgery for IUA, referral included a number of women who were considered to have inoperable disease and had failed treatment elsewhere.
The location, extent and type of adhesions were recorded and classified according to the European Society of Hysteroscopy (ESH) classification system (Wamsteker, 1984) . Following surgery, women received only conjugated equine oestrogen 2.5 mg/day (Ayerst, Wyeth Australia Pty Ltd., Baulkam Hills, NSW, Australia) for 21 of 28 days, and were discharged the day of surgery. Clinical review was scheduled 6-8 weeks following the index procedure, and repeat hysteroscopy and adhesiolysis was performed if symptoms persisted until there was complete restoration of the endometrial cavity.
A questionnaire was used to collect data, with women asked to recall their menstrual, pain and fertility symptoms prior to, following treatment, and presently. The primary outcome of the study was to determine live birth rate, with other fertility, obstetric and neonatal data recorded. Obstetric outcomes were determined by a 14-year follow-up questionnaire and audit of all women included in a National hospitals' database. Surgical outcomes including clinical symptoms, the number of procedures and procedural complications are reported secondarily.
Statistical analyses
Comparisons pre-and post-treatment were undertaken using the independent samples t-test and its non-parametric equivalent where appropriate, the latter being used where data did not satisfy the assumption of equal variances (Kolgarov-Smirnov test). Association of dichotomous measures between the groups were assessed utilizing the Chi-squared test, with Fisher's exact test used as appropriate due to the small sample sizes. Continuous variables were assessed using the Student t-test. P-values are two tailed, unless otherwise indicated, and considered statistically significant if <0.05. The time to pregnancy was assessed using the inverse Kaplan Meier survival curve. Confidence intervals are reported by intention to treat analysis.
Results
For the 14-year study duration, 176 women were identified from the departmental database as having surgery for IUAs, with 154/176 (87.5%), meeting inclusion and exclusion criteria, and having adequate information available for data extraction. Questionnaires were received from 131/154 (85.1%) of these women, whose demographic data, cause of IUAs and ESH grade of adhesions are documented in Table I . The 10 of the 154 women had concurrent laparoscopy to investigate coexisting pathology for pelvic pain and infertility, with 6/154 (3.9%) having biopsy proven endometriosis and all macroscopic disease removed at this procedure, 1/154 woman (0.6%) had pelvic adhesions divided. A total of 259 hysteroscopic procedures were performed in the 154 women and complications are reported per procedure. There were 8/259 (3.1%) complications including maximum fluid deficit reached in 2/259 (0.8%), excessive surgical time in 1/259 (0.4%), uterine perforation 3/259 (1.2%) and infection in 2/259 (0.8%). In all cases where perforation occurred, this was recognized contemporaneously by the passage of radio-opaque contrast into the peritoneal cavity with no sequelae noted after antibiotic administration and observation. There were no serious adverse surgical events recorded.
Fertility outcomes
Post-operatively, only 124/154 (80.5%) women in the cohort tried to become pregnant, and fertility outcomes are reported per woman attempting pregnancy. A total of 98/124 (79.0% CI: 63.6-83.1%) achieved at least one pregnancy, with 79/124 (63.7% CI: 51.3-70.7%) women having at least one livebirth and 29/124 (23.4% CI: 18.8-37.1%) having miscarriages. Pregnancy following expectant management occurred in 78/124 (62.9% CI: 50.6-70.1%), with 40/124 (32.3% CI: 25.9-45.5%) requiring assistance to become pregnant and 6/124 (4.8%) women did not report how they became pregnant. Of the 40 women having any medical assistance to achieve pregnancy, 34/40 (85.0%) had IVF/ICSI (with two couples requiring ICSI for male factor subfertility), 2/40 (5.0%) IUI, 1/40 (2.5%) had ovulation induction with clomiphene citrate, 2/40 (5.0%) women used a donor oocyte, and 1/40 (2.5%) the type of assistance was not recorded. Additional treatments utilized to augment endometrial thickness in this group included 25 µg oestradiol patch in 5/40 (12.5%), and aspirin in 1/40 (2.5%) women. The time to become pregnant is demonstrated in Fig. 1 grade III, 13/98 (13.3%) were grade IV, and in 1/98 (1.0%) the grade of adhesions was not recorded.
Obstetric outcomes
Overall, there were 93 livebirths in 79 women, with 1 woman reporting an unplanned pregnancy. These women collectively had 157 pregnancies subsequent to index surgery. Figure 2 illustrates the outcomes of all pregnancies. Overall, 66 women had 1 livebirth, 12 women had 2 live births and 1 woman had 3 live births. Detailed obstetric and neonatal outcomes were reported for 71/79 women, and these are shown in Tables II and III . There was one set of twins, accounting for the 72 complete datasets of neonatal outcomes. having a hysterectomy (four postpartum and one due to dysmenorrhoea) following their index surgery. In 9/154 (5.8%), menstrual activity at the time of the questionnaire was not recorded. There were no differences in the symptom of pain across the grades of IUA, χ 2 = 1.761, P = 0.623. For women with dysmenorrhoea, the median duration of pain was 10 months (range: 1-96 months 
Clinical outcomes
Discussion
For women with IUAs wishing to become pregnant, live birth rate is the only important clinical outcome, and from this series, 63.7% of women achieved this aim. Menstrual changes that include a change from amenorrhoea and 'light periods' to 'normal' periods have a more limited role as an outcome, since they do not necessarily correlate with the live birth rate. Indeed the amenorrhoea rate from this series was not statistically significantly improved, although a strong argument may be made for both a clinical improvement (from 48.1% pre-surgery to 87.7% post-surgery) and many women achieved live birth-the ultimate indicator of success. This important difference between clinical and statistical data should not be underestimated (Farland et al., 2016) . Whilst the retrospective nature of this study may lead to recall bias, pregnancy outcomes, particularly live births are substantially less likely to be disremembered, whereas the pattern of menstruation and the degree of pain experienced is more subjective and are not the focus of our analyses. We utilized a National obstetric database to cross-refer obstetric and neonatal outcomes and these data are important to consider when counselling women presenting with infertility and IUA. Despite a high chance of pregnancy success following index surgery in our data, these pregnancies were frequently complicated by placental related morbidity for the mother and offspring. Early data report few obstetric complications in women treated hysteroscopically for AS (Valle and Sciarra, 1988) , although contemporary series with rigorous follow-up demonstrate compelling evidence for malplacentatation. These include the of risk of placenta accreta in a subsequent pregnancy to be increased at 2.5% (Roge et al., 1996; Protopapas et al., 1998; Feng et al., 1999; Nasr et al., 2000; Zikopoulos et al., 2004; March, 2008; Yu et al., 2008a) and our results suggest a trebling of this rate at 8.0% as well as placental related neonatal complications such as premature birth and low birth weight compared to the national database (AIHW, 2015) . A higher baseline pregnancy rate achieved in our cohort may contribute to this skewing of the data, with women treated with more severe adhesions achieving a pregnancy in the first instance and this pathological process flowing downstream to the feto-maternal interface. Alternatively, this discrepancy may be due to underreporting and publication bias in other reported series.
The postpartum hysterectomy rate from our series is also concerning, affecting 4/85 (4.7%) of deliveries. The extended length of followup reported within our series may contribute to this figure and it may be once again explained by the relatively high number of women conceiving within our series compared to others. Importantly, these data highlight the need to adequately counsel women having a procedure for IUAs regarding subsequent pregnancy and its risks and to inform obstetricians to treat any pregnancy as medium-high risk and be aware of all of the potential outcomes and prepare for them.
Asherman's original description of the syndrome was of IUA and infertility following traumatic postpartum or post abortal curettage (Asherman, 1948 (Asherman, , 1950 (Asherman, , 1952 . Operative hysteroscopic surgery did not exist at that time, nor did procedures such as B-Lynch suture for postpartum haemorrhage and both of these interventions can lead to IUAs (Sentilhes et al., 2010a; Rathat et al., 2011; Ibrahim et al., 2013; Fuglsang, 2014; Kjer, 2014) , although the pathophysiology of the adhesion formation may be different. We included all women with IUAs and a desire for pregnancy in our cohort, since their aim is the samelive birth-and although our data are underpowered for meaningful comparison between these two groups, we did not show a significant difference for live birth rate in this series for the different outcomes, with non-pregnancy IUAs having a lower chance of pregnancy than women with classic AS.
Adhesion severity is negatively correlated with subsequent term pregnancy rate, with previous data reporting~80% success rate for women with mild, 65% moderate and only 30% in women with severe IUAs (Valle and Sciarra, 1988; Yu et al., 2008a,b; Roy et al., 2010) , suggesting that higher grade IUAs and its subsequent treatment may lead to marked uterine impairment. Data from our study concur with these findings. This may be in part due to women with severe IUAs requiring multiple procedures to treat disease (Kodaman and Arici, 2007; Thomson et al., 2007) with the combined rate of anatomical restoration from combined large series 640/815 (78.5%, range: 44-93%) (Fedele et al., 1986; Pace et al., 2002; Fernandez and Al-Najjar, 2006; Hanstede et al., 2015) , but severity dependent, with restoration reported as only 31/71 (44%) in women with grade 3 or higher IUAs (Fernandez and Al-Najjar, 2006) . The initiating event for IUA development is unclear, although a thin endometrium, potentially caused by an impairment of the normal process of endometrial growth (Miwa et al., 2009) has been identified as an independent and critical factor for implantation failure (Shufaro et al., 2008; Gleicher et al., 2011; Zhao et al., 2012; Fang et al., 2016) . Since angiogenesis is essential to promote endometrial growth after menstruation and to provide a vascular receptive endometrium for implantation (Smith, 1998 (Smith, , 2000 , decreased vascularization due to either an initial surgical insult or treatment for IUAs may impair this pathway. Angiographic studies on women with IUA demonstrates reduced myometrial blood flow, with widespread vascular occlusion that may in part explain the endometrial atrophy, poor receptivity and recurrent miscarriage suffered in this group of women (Polishuk et al., 1977) .
Results from this study indicate that hysteroscopic management of IUAs may result in pregnancy rates exceeding 60%, with more severe adhesions having a worse prognosis and requiring more surgical treatments. However, these pregnancies are more likely complicated by premature delivery, and the sequelae of abnormal placentation. Altered biochemical milieu or aberrant vascularization may be at the core of the pathological process, and consequently pregnant women treated for IUAs must be treated as high risk, with adequate antenatal and intrapartum surveillance. Multi-centred collaboration is recommended to undertake adequately powered prospective studies in this important area, but the limitations given the reported variance in individual surgical techniques and low prevalence are recognized.
